Part:BBa_K2923018:Experience
Contents
Introduction
To validate the designed constructs we decided to test two different aptazymes: Theophylline switch-off (stop auto-cleavage in presence of ligand) and Guanine switch-on (active auto-cleavage in presence of ligand). For negative control, we choose an inactive form of aptazyme: mutation at the ribozyme domain. iGEM Strasbourg designed construct requires the use of aptazyme linked to MS2 and PP7 stem-loops. The following results described MS2-MS2-Aptazyme-PP7-PP7 activity in in-vitro and in-vivo assays.
In-vitro assay of BBa_K2923018
In order to check MS2-MS2-Theophylline-PP7-PP7 cleavage activities, in-vitro transcription products were analyzed by 2% agarose gel with urea (Figure 1).
In-vitro assay show, that PP7-PP7-Theophylline-MS2-MS2 constructs have kept 100% of their ribozyme activity. Also, inactive aptazyme did not present aptazyme catalytic activity, which confirms their use as efficient negative control.
In-vivo: ß-galactosidase assay in the absence of ligand
Before to start an in vivo experiment on aptazymes, we characterized the constructs created by Berry KE and Hochschild as positive and negative controls. A ß-galactosidase activity positive control also called BH3 corresponds to BBa_K2923000. A ß-galactosidase activity negative control, called BH2 correspond to empty plasmid backbone.
Theophylline aptazyme is switch-off (self-cleaves in absence of ligand) and prevents ß-galactosidase transcription. It was analyze in presence of its inactive form and BH2, BH3 controls (Figure 2).
User Reviews
UNIQ5d8ffdf614c23c2f-partinfo-00000001-QINU UNIQ5d8ffdf614c23c2f-partinfo-00000002-QINU